Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLXIPL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SLBP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SCOC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | KIF21B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SFXN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | L1CAM | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | SIGMAR1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | PLXNC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ESCO2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |